# Docetaxel

## TAXOTERE inj 80mg/4mL

| 藥物代碼           | ITAX8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, head & neck cancer.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 副作用             | Hematologic reactions especially neutropenia, fever, hypersensitivity reactions, fluid retention, GI disturbances, cutaneous reactions, neurologic symptoms, asthenia, alopecia.Cardiovascular: Edema (47% to 64.1% ), Vasodilatation (27% )Dermatologic: Alopecia (56.3% to 97.8% ), Disorder of nail (11.4% to 18.5% ), Disorder of skin AND/OR subcutaneous tissue, Nail changes (8.1% to 30.6% ), Pruritus, RashGastrointestinal: Diarrhea (32.8% to 42.6% ), Nausea (38.8% to 80.5% ), Stomatitis (41.7% to 69.4% ), Vomiting (22.3% to 44.5% )Hematologic: Anemia (89.1% to 93.6% ), Leukopenia (95.6% to 98.6% ), Neutropenia (71.4% to 99.5% )Neurologic: Asthenia (61.8% to 80.8% ), NeuropathyReproductive: Amenorrhea (61.7% )Other: Fever of unknown origin (31.2% to 46.5% ) |
| 禁忌               | Severe hypersensitivity to docetaxel or any component of the formulation; severe hypersensitivity to other medications containing polysorbate 80; neutrophil count <1,500/mm3. Canadian labeling: Additional contraindications (not in the US labeling): Severe hepatic impairment; pregnancy; breastfeeding                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量           | 75-100 mg/m2 as a 1-hr infusion every 3 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 肝功能異常         | 需 調 整 劑 量  使用單一藥物100 mg / m 2之藥物動力學資料，ALT和/或AST大於正常範圍上限1.5倍和鹼性磷酸大於2.5倍，建議劑量為75 mg / m2。血清膽紅素高於正常值，和/或ALT和AST>正常值3.5倍且鹼性磷酸>正常值 6倍患者，沒有減量建議，除非特殊情況，否則不應使用。併用Cisplatin和5-FU治療胃癌患者 臨床研究排除ALT和/或AST>1.5倍正常值與鹼性磷酸>2.5正常值，膽紅素>正常值的患者；對於這些患者，沒有減量建議，除非特殊情況，否則不應使用。另一方面，尚無肝損傷患者使用之研究報告。                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期用藥建議     | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 注意事項           | 1. 本品為化療藥物，輸注時需注意注射部位，防止藥液外滲。 2. 稀釋溶液與器具應使用玻璃、聚丙烯(polypropylene)、聚烯(polyolefin)材質，不可使用含PVC塑膠材質。給藥時應使用 polyethylene 材質的輸液套。 3. 配製好的輸注溶液濃度避免超過 0.74 mg/mL，配置好6小時內以靜脈輸注方式使用 (包含輸注時間)，在低於25℃以下給予病患。使用前應再次目視檢查，若有沉澱物或結晶應予以丟棄。 4. 注射前應先給予預防過敏的藥物。 5. 監測CBC、肝功能。                                                                                                                                                                                                                                                                                                                                                            |

## Taxotere inj 20mg/1mL

| 藥物代碼           | ITAXO                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, head & neck cancer.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 副作用             | Hematologic reactions especially neutropenia, fever, hypersensitivity reactions, fluid retention, GI disturbances, cutaneous reactions, neurologic symptoms, asthenia, alopecia.Cardiovascular: Edema (47% to 64.1% ), Vasodilatation (27% )Dermatologic: Alopecia (56.3% to 97.8% ), Disorder of nail (11.4% to 18.5% ), Disorder of skin AND/OR subcutaneous tissue, Nail changes (8.1% to 30.6% ), Pruritus, RashGastrointestinal: Diarrhea (32.8% to 42.6% ), Nausea (38.8% to 80.5% ), Stomatitis (41.7% to 69.4% ), Vomiting (22.3% to 44.5% )Hematologic: Anemia (89.1% to 93.6% ), Leukopenia (95.6% to 98.6% ), Neutropenia (71.4% to 99.5% )Neurologic: Asthenia (61.8% to 80.8% ), NeuropathyReproductive: Amenorrhea (61.7% )Other: Fever of unknown origin (31.2% to 46.5% ) |
| 禁忌               | Severe hypersensitivity to docetaxel or any component of the formulation; severe hypersensitivity to other medications containing polysorbate 80; neutrophil count <1,500/mm3. Canadian labeling: Additional contraindications (not in the US labeling): Severe hepatic impairment; pregnancy; breastfeeding                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量           | 75-100 mg/m2 as a 1-hr infusion every 3 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 肝功能異常         | 需 調 整 劑 量  使用單一藥物100 mg / m 2之藥物動力學資料，ALT和/或AST大於正常範圍上限1.5倍和鹼性磷酸大於2.5倍，建議劑量為75 mg / m2。血清膽紅素高於正常值，和/或ALT和AST>正常值3.5倍且鹼性磷酸>正常值 6倍患者，沒有減量建議，除非特殊情況，否則不應使用。併用Cisplatin和5-FU治療胃癌患者 臨床研究排除ALT和/或AST>1.5倍正常值與鹼性磷酸>2.5正常值，膽紅素>正常值的患者；對於這些患者，沒有減量建議，除非特殊情況，否則不應使用。另一方面，尚無肝損傷患者使用之研究報告。                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期用藥建議     | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 注意事項           | 1. 本品為化療藥物，輸注時需注意注射部位，防止藥液外滲。 2. 稀釋溶液與器具應使用玻璃、聚丙烯(polypropylene)、聚烯(polyolefin)材質，不可使用含PVC塑膠材質。給藥時應使用 polyethylene 材質的輸液套。 3. 配製好的輸注溶液濃度避免超過 0.74 mg/mL，配置好6小時內以靜脈輸注方式使用 (包含輸注時間)，在低於25℃以下給予病患。使用前應再次目視檢查，若有沉澱物或結晶應予以丟棄。 4. 注射前應先給予預防過敏的藥物。 5. 監測CBC、肝功能。                                                                                                                                                                                                                                                                                                                                                            |

